Annual Accounts Receivable
$7.90 B
+$819.00 M+11.56%
31 December 2023
Summary:
Elevance Health annual accounts receivable is currently $7.90 billion, with the most recent change of +$819.00 million (+11.56%) on 31 December 2023. During the last 3 years, it has risen by +$2.22 billion (+39.10%). ELV annual accounts receivable is now at all-time high.ELV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$7.21 B
-$831.00 M-10.34%
30 September 2024
Summary:
Elevance Health quarterly accounts receivable is currently $7.21 billion, with the most recent change of -$831.00 million (-10.34%) on 30 September 2024. Over the past year, it has dropped by -$693.00 million (-8.77%). ELV quarterly accounts receivable is now -40.08% below its all-time high of $12.03 billion, reached on 31 March 2023.ELV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELV Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -8.8% |
3 y3 years | +39.1% | +26.9% |
5 y5 years | +57.6% | +43.8% |
ELV Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +39.1% | -40.1% | +26.9% |
5 y | 5 years | at high | +57.6% | -40.1% | +43.8% |
alltime | all time | at high | >+9999.0% | -40.1% | +9323.5% |
Elevance Health Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $7.21 B(-10.3%) |
June 2024 | - | $8.04 B(-10.0%) |
Mar 2024 | - | $8.93 B(+13.0%) |
Dec 2023 | $7.90 B(+11.6%) | $7.90 B(+0.2%) |
Sept 2023 | - | $7.88 B(+6.1%) |
June 2023 | - | $7.43 B(-38.2%) |
Mar 2023 | - | $12.03 B(+69.9%) |
Dec 2022 | $7.08 B(+24.7%) | $7.08 B(-32.9%) |
Sept 2022 | - | $10.55 B(-0.4%) |
June 2022 | - | $10.60 B(-6.4%) |
Mar 2022 | - | $11.33 B(+99.4%) |
Dec 2021 | $5.68 B(+7.6%) | $5.68 B(-39.3%) |
Sept 2021 | - | $9.36 B(-0.9%) |
June 2021 | - | $9.44 B(+54.5%) |
Mar 2021 | - | $6.11 B(+15.8%) |
Dec 2020 | $5.28 B(+5.3%) | $5.28 B(-36.6%) |
Sept 2020 | - | $8.33 B(+5.2%) |
June 2020 | - | $7.92 B(-5.8%) |
Mar 2020 | - | $8.40 B(+67.5%) |
Dec 2019 | $5.01 B(-25.6%) | $5.01 B(+4.9%) |
Sept 2019 | - | $4.78 B(-34.4%) |
June 2019 | - | $7.29 B(-3.4%) |
Mar 2019 | - | $7.54 B(+11.8%) |
Dec 2018 | $6.74 B(+9.0%) | $6.74 B(-2.9%) |
Sept 2018 | - | $6.94 B(+0.4%) |
June 2018 | - | $6.92 B(+10.6%) |
Mar 2018 | - | $6.26 B(+1.1%) |
Dec 2017 | $6.18 B(+5.5%) | $6.18 B(+8.7%) |
Sept 2017 | - | $5.69 B(-6.8%) |
June 2017 | - | $6.11 B(+5.8%) |
Mar 2017 | - | $5.77 B(-1.5%) |
Dec 2016 | $5.86 B(+27.3%) | $5.86 B(+12.4%) |
Sept 2016 | - | $5.21 B(-0.9%) |
June 2016 | - | $5.26 B(+5.3%) |
Mar 2016 | - | $5.00 B(+8.6%) |
Dec 2015 | $4.60 B(-4.6%) | $4.60 B(+4.6%) |
Sept 2015 | - | $4.40 B(-10.9%) |
June 2015 | - | $4.94 B(-0.5%) |
Mar 2015 | - | $4.96 B(+2.9%) |
Dec 2014 | $4.83 B(+21.6%) | $4.83 B(+8.7%) |
Sept 2014 | - | $4.44 B(-2.4%) |
June 2014 | - | $4.55 B(+2.0%) |
Mar 2014 | - | $4.46 B(+12.3%) |
Dec 2013 | $3.97 B | $3.97 B(-1.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2013 | - | $4.01 B(-7.3%) |
June 2013 | - | $4.33 B(+5.6%) |
Mar 2013 | - | $4.10 B(+11.2%) |
Dec 2012 | $3.69 B(+8.4%) | $3.69 B(+1.1%) |
Sept 2012 | - | $3.65 B(-6.3%) |
June 2012 | - | $3.89 B(+4.5%) |
Mar 2012 | - | $3.72 B(+9.4%) |
Dec 2011 | $3.40 B(+11.9%) | $3.40 B(+2.8%) |
Sept 2011 | - | $3.31 B(+6.7%) |
June 2011 | - | $3.10 B(-6.1%) |
Mar 2011 | - | $3.30 B(+8.6%) |
Dec 2010 | $3.04 B(-7.3%) | $3.04 B(-13.1%) |
June 2010 | - | $3.50 B(+6.1%) |
Mar 2010 | - | $3.30 B(+0.5%) |
Dec 2009 | $3.28 B(+7.8%) | $3.28 B(+0.1%) |
Sept 2009 | - | $3.28 B(-5.3%) |
June 2009 | - | $3.46 B(-1.9%) |
Mar 2009 | - | $3.53 B(+15.9%) |
Dec 2008 | $3.04 B(+6.0%) | $3.04 B(-6.8%) |
Sept 2008 | - | $3.27 B(+1.9%) |
June 2008 | - | $3.20 B(+1.1%) |
Mar 2008 | - | $3.17 B(+10.3%) |
Dec 2007 | $2.87 B(+22.9%) | $2.87 B(+2.5%) |
Sept 2007 | - | $2.80 B(+6.6%) |
June 2007 | - | $2.63 B(-5.9%) |
Mar 2007 | - | $2.79 B(+19.5%) |
Dec 2006 | $2.34 B(+1.7%) | $2.34 B(-49.5%) |
Sept 2006 | - | $4.63 B(+9.8%) |
June 2006 | - | $4.21 B(+84.7%) |
Mar 2006 | - | $2.28 B(-0.6%) |
Dec 2005 | $2.30 B(+45.8%) | $2.30 B(+30.6%) |
Sept 2005 | - | $1.76 B(+3.2%) |
June 2005 | - | $1.70 B(+1.3%) |
Mar 2005 | - | $1.68 B(+6.7%) |
Dec 2004 | $1.57 B(+1958.3%) | $1.57 B(+41.1%) |
Sept 2004 | - | $1.12 B(+0.3%) |
June 2004 | - | $1.11 B(+1.8%) |
Mar 2004 | - | $1.09 B(+2.6%) |
Sept 2003 | - | $1.06 B(+6.7%) |
June 2003 | - | $997.70 M(+10.4%) |
Mar 2003 | - | $903.80 M(+1081.4%) |
Dec 2002 | $76.50 M | $76.50 M(-2.9%) |
Sept 2002 | - | $78.80 M(+1.9%) |
June 2002 | - | $77.30 M(-0.4%) |
Mar 2002 | - | $77.60 M |
FAQ
- What is Elevance Health annual accounts receivable?
- What is the all time high annual accounts receivable for Elevance Health?
- What is Elevance Health quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Elevance Health?
- What is Elevance Health quarterly accounts receivable year-on-year change?
What is Elevance Health annual accounts receivable?
The current annual accounts receivable of ELV is $7.90 B
What is the all time high annual accounts receivable for Elevance Health?
Elevance Health all-time high annual accounts receivable is $7.90 B
What is Elevance Health quarterly accounts receivable?
The current quarterly accounts receivable of ELV is $7.21 B
What is the all time high quarterly accounts receivable for Elevance Health?
Elevance Health all-time high quarterly accounts receivable is $12.03 B
What is Elevance Health quarterly accounts receivable year-on-year change?
Over the past year, ELV quarterly accounts receivable has changed by -$693.00 M (-8.77%)